Description
Medicines for first-line antituberculosis agents for continuous therapy of patients with tuberculosis for the period 2025-2027
J04AM02, Rifampicin, Isoniazid, 150mg + 75mg, Film-coated tablet; J04AM06, Rifampicin, Isoniazid, Pyrazinamide, Ethambutol, 150 mg + 75 mg + 400 mg + 275 mg, film-coated tablet; J04AC01, Isoniazid, 100 mg, film-coated tablet; J04AC01, Isoniazid, 300 mg, film-coated tablet; J04AB02, Rifampicin, 300 mg, tablet/capsule; J04AK02, Ethambutol, 400 mg, film-coated tablet; J04AK02, Ethambutol, 100 mg, film-coated tablet; J04AK01, Pyrazinamide, 500 mg, tablet; J01GA01, Streptomycin sulphate, 1 g, powder for solution for injection; J04AD01, Protionamide, 250 mg, film-coated tablet; J04AB01, Cycloserine, 250 mg, capsule/tablet; V07AB, Water for injection (solvents and diluting agents), 2 ml, vehicle for parenteral use
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago
The buyer
Full buyer profileMinistry of Health of the Republic of North Macedonia
- notices in the register
- 23
Who wins its contracts
- of its calls state an estimated value
- 0%
1 open tender right now
Market context
- open now in Medical equipment & pharmaceuticals
- 8,460
- median open notice
- €308,919
Similar tenders
Open now
Awarded before
Never miss a tender like this
34 new notices in Medical equipment & pharmaceuticals in North Macedonia in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.